Premium
P2‐015: TOWARD AN UNDERSTANDING OF THE IMMUNOLOGICAL BASES OF THE EFFICACY OF RESVERATROL WITH RED WINE POLYPHENOLS IN PD WITH AD CHANGES WITH SUGGESTED TRIAL DESIGN
Author(s) -
Barber Elizabeth K.
Publication year - 2018
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2018.06.699
Subject(s) - resveratrol , neuroprotection , pharmacology , medicine , carbidopa , parkinson's disease , levodopa , inflammation , dopamine , disease
level) 15, severe stage (dementia at TDR-3 level) – 11. Conservative treatment (Memantine or Rivastigmine). Results: In the Test Group, all 48 (100%) patients showed improvement in cerebral microcirculation and 10-20% increase in cerebral temporal lobes volume, which indicated development of cerebral reparative processes and neurogenesis. The process was accompanied by decrease in dementia level and cognitive functions restoration.